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Abstract 
 
 BACKGROUND Trigeminal Neuralgia (TN) is a well-recognized facial pain syndrome. Discrete 
forms with disparate pain symptoms include TN1 and TN2, however, atypical facial pain includes 
neuralgiform pain along a spectrum. The majority of TN is diagnosed in the adult population. Case 
reports and series in children present TN as a similar diagnosis which can be similarly treated as in 
adults. This manuscript reviews pertinent literature and presents two pediatric TN cases 
successfully treated with microvascular decompression (MVD).  
CASE DESCRIPTION Two pediatric patients (ages 12 and 15) were identified with TN that was 
refractory to previous medical therapy. The patients were both deemed appropriate surgical 
candidates and were treated with MVD to manage their TN. TN compression was arterial in both 
cases and involved portions of the anterior inferior cerebellar artery. Patient 1 was found to be 
pain-free 6 months following the procedure. Patient 2 was pain-free immediately following the 
procedure and has since been weaned off preoperative symptomatic management. The most recent 
follow-up is 12 and 8 months, respectively, with continued pain freedom.  
CONCLUSIONS There are few reports on the effectiveness of MVD in the pediatric population 
for the management of TN. Supporting literature, as well as the cases presented, demonstrate that 
MVD is an effective treatment for pediatric patients in managing their TN. Furthermore, there 
appears to be minimal side effects, with excellent pain relief with MVD in this patient population.   
 
 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
  Chicoine 
 2 
Trigeminal neuralgia (TN) is a disorder characterized by recurrent paroxysmal attacks of intense 
unilateral facial pain occurring in the distribution of the trigeminal nerve.1 The first detailed 
description of TN was provided by John Locke in 1677. He observed this condition while treating 
the countess of Northumberland, wife of the English Ambassador who experienced intermittent 
episodes of intense face and jaw pain. In 1756, Nicalaus André further described the condition 
giving the name “Tic Doulourex” to characterize the facial convulsions that accompany the 
severely painful episodes. It wasn’t until 1779 that John Hunter first recognized the disease as a 
form of nervous disorder.2 Present day descriptions of TN in adults have designated classic (TN1) 
and atypical (TN2) forms of the disorder. 
Patients with TN1 complain of unilateral, episodic, lancinating pain in the one or more 
subdivisions of the trigeminal nerve. TN1 is caused by patient-specific somatosensory triggers. 
The etiology of TN1 remains unknown, although commonly there is compression of the root entry 
zone of the trigeminal nerve via an artery or vein, most commonly the superior cerebellar artery.1,3 
Over time, chronic compression leads to demyelination which can lead to ectopic impulses and 
ephaptic neurotransmission. It is believed that ephaptic neurotransmission alters afferent 
neurological input, resulting in the disinhibition of the pain pathways in the spinal trigeminal 
nucleus.3-5    
Atypical TN (TN2) is characterized by similar symptoms to classic TN with persistent 
burning facial pain of moderate to severe intensity.1 Etiologies of atypical TN include herpes 
zoster, posttraumatic neuropathy, multiple sclerosis, space occupying lesion such as a tumor, cyst, 
or lipoma6 among others.7-12  
TN occurs in 4–13/100,000 people,13,14 and typically affects the older adult population, 
with a mean onset age of 63.15 TN cases occur before age 20 in 1–1.5% of diagnoses, which may 
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reflect a true lower incidence in children or may be confounded by a lack of diagnostic suspicion 
in young patients.16,17 In a series of seven patients with mean age of symptom onset at age 19.6 
years, patients were more likely to be female, were unlikely to have first division trigeminal pain, 
and had poorer pain outcome than adult populations.17 
Initial management of TN is with symptomatic management; there are no disease 
modifying medical treatments. Carbamazepine is a common first-line option with oxcarbazepine, 
baclofen, and lamotrigine as alternatives.18 Choice of medical therapy in pediatric patients include 
carbamazepine, phenytoin, baclofen, sodium valproate, sumatriptan, and acyclovir. 19 In patients 
who are refractory to medical therapy, surgical treatment can be a viable option.  
The surgical interventions used to treat TN include microvascular decompression (MVD), 
stereotactic radiosurgery (SRS) 20-23 or rhizotomy with radiofrequency thermocoagulation, 
mechanical balloon compression, or glycerol injection. 24-28 In this paper we report our experience 
in two cases of pediatric TN that were successfully treated using MVD technique. 
Case 1 
 The patient is a 15-year-old female who presents with medically intractable TN. She 
started developing episodes of facial pain at 3 years old which was refractory to medical 
management.  Her symptoms were described as an episodic, right-sided, lancinating facial pain 
located in the V2 and V3 distributions.  These episodes were exacerbated by head movement and 
brushing hair on the side of her face which prompted her to cut her hair short. Her pain episodes 
initially involved only the right side of the face. However, the pain episodes have recently 
progressed to involve the left side of the face. Interestingly, the left-sided facial pain will 
occasionally occur immediately following a right-sided episode and never occurs independently. 
The facial pain episodes were frequently followed by a headache and  would awaken the patient 
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from sleep. She has multiple episodes throughout the day.  Occasionally, warm compresses or 
distraction provided temporary relief from the pain. 
The patient was placed on carbamazepine but developed excessive somnolence with its 
use.  Phenytoin provided some relief initially but lost effectiveness over time and caused an 
elevation in the patient’s liver enzymes. She was started on oxcarbazepine and gabapentin, but 
these also have become ineffective over time.  
 
The patient’s past medical history includes type 2 diabetes, Asperger’s syndrome, asthma, 
anxiety, depression, and obsessive-compulsive disorder (OCD).  She did note that flares of 
anxiety, depression, or OCD would worsen her symptoms of TN. An MRI workup revealed a 
torturous anterior inferior cerebellar artery on the right side in the vicinity of the dorsal root entry 
zone (DREZ) of the trigeminal nerve (Figure 1). The patient was determined to be a good 
candidate for MVD. 
A right retromastoid craniectomy  was performed with the patient in a left lateral decubitus 
position. The cerebellum was retracted medially and inferiorly to access the cerebellopontine 
angle. The petrosal vein was identified which was then coagulated and divided. The facial and 
vestibulocochlear nerves were identified, and the trigeminal nerve located just medial to that 
within the field of view.  We carefully dissected circumferentially around the trigeminal nerve.  
An indentation was found on the inferior aspect of the nerve away from the DREZ. This was 
associated with a loop of the anterior inferior cerebellar artery, which was as the radiology 
suggested throughout the surgery.  Once the trigeminal nerve was dissected away from the artery, 
Teflon balls were placed between the artery and nerve. 
The patient had an uncomplicated postoperative course, except for occasional migraines 
and mild muscle stiffness around the incisional site. She had no further episodes of facial pain and 
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was weaned from preoperative TN medications by 5 months following the procedure.  
 
Case 2 
A 12-year-old female presented with several episodes of severe facial pain that occurred 
over the course of three weeks. The patient’s pain was typical of left type 1 TN that was described 
as intermittent, explosive attacks of lancinating pain distributed primarily along the V3 branch of 
the left trigeminal nerve with some involvement of V1 and V2. The affected areas included the 
jaw, cheek, ear, temporal, and preauricular regions. The trigger mechanism for these episodes 
included chewing, light touch from slight breeze or raindrops. She also experienced pain with 
bumps or vibration while riding in a car.  
She was initially treated with a course of prednisone that provided only minimal relief. She 
also received several combinations of therapies including indomethacin prochlorperazine, and 
chlorpromazine all were ineffective in reducing the frequency and intensity of the pain episodes. 
Carbamazepine, naproxen, gabapentin or valacyclovir also did not yield any benefit. 
These episodes of TN were severely limiting, preventing her from attending school or 
participating in cheerleading. Her past medical history was unremarkable. Physical examination 
did not reveal any significant neurological findings other than notable allodynia around the left 
temporal region extending into the mandibular and maxillary region. MRI with and without 
contrast revealed an area of possible trigeminal nerve compression at the dorsal root entry zone 
involving a loop of blood vessels, likely the Labyrinthine artery, a named branch of the anterior 
inferior cerebellar artery (AICA) (Figure 2). The patient was referred to neurosurgery for a left 
retrosigmoid craniectomy and microvascular decompression. 
The patient was placed in a three-quarter prone position, facilitating a retrosigmoid 
approach to access the cerebellopontine angle.  The retractor system was incrementally advanced 
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until the superior petrosal vein was identified.  This was coagulated and cut in two places as there 
were two tributaries.  The trigeminal, facial, and vestibulocochlear nerves were then identified. 
There was no arterial compression of the left trigeminal nerve; however, a circumferential venous 
complex that was compressing the nerve was identified which was not identifiable on imaging. 
This was dissected from the trigeminal nerve. The shoulder and axilla of the trigeminal nerve were 
inspected, and no other compressive areas were identified. Since a compressive vascular lesion 
was identified neurolysis was not performed.  At this point, the nerve was completely 
decompressed and Teflon pledgets were placed to prevent further vascular compression (video). 
 
Following the procedure, the patient had uneventful recovery and she experienced no 
further episodes of neuralgia. She was able to discontinue all medications and all provocative 
maneuvers that previously elicited pain would no longer trigger pain episodes. The patient 
returned to school, resumed previous extracurricular activities, and continued to remainpain-free at 
6 months postoperatively. 
Discussion 
       
TN is an uncommon diagnosis and can be challenging to treat in the pediatric population. 
Most descriptions of pediatric TN in the literature are consistent with Type 1 TN which is similar 
to the experience at our institution.  Treatment is crucial as the scarcity of pain-free episodes may 
cause performance decreases in essential activities.19 Medical management of patients with TN 
begins with pharmacological intervention. In a study by Railei, an 8-year-old patient was treated 
for pediatric trigeminal neuralgia with 15mg/kg/day of carbamazepine.29 Combination treatment 
with carbamazepine has also been utilized. In a study by Lopez, a 12-year-old female patient was 
treated with 1200mg/day of gabapentin in combination with 800mg/day of carbamazepine.3 High 
doses of amitriptyline, phenytoin, baclofen, sodium valproate, sumatriptan, and acyclovir with a 3-
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day dose of methylprednisolone have also be used for treatment in pediatric cases.3 
       Surgical intervention is indicated when pain is refractory to medical therapy. Approximately 
one-third of patients do not achieve adequate symptom reduction with medical therapy alone.30 It 
should be determined as soon as possible if surgical intervention is necessary as prolonged 
symptoms of TN can eventually lead to disinhibition of pain pathways in the spinal trigeminal 
nucleus causing persistent background pain and possible progression from TN1 to TN2. Earlier 
decision for surgery is even more critical in the pediatric population in which low suspicion of the 
disease may lead to delays in diagnosis and application of appropriate therapies. Moreover, in the 
pediatric population with TN1 and documented compression by imaging, MVD may be indicated 
before medical treatment according to Bender et al.20 
Table 1 tabulates eight manuscripts reporting pediatric TN; four of five manuscripts 
commenting on offending vessels report venous compression. This suggests a high proportion of 
venous compression in pediatric TN compared to the adult literature. Our series demonstrates one 
of two cases with clear circumferential venous constriction at the trigeminal root entry zone with 
video demonstrating surgical decompression. Surgical procedures used to treat TN include MVD, 
SRS, rhizotomy with radiofrequency thermocoagulation, mechanical balloon compression, or 
chemical (glycerol) injection. 24-28 The American Academy of Neurology and the European 
Federation of Neurological Societies  concluded that MVD, rhizotomy, and gamma knife 
radiosurgery are potentially effective procedures for this condition.18 In the pediatric population, 
Solth found success utilizing MVD in an 11-year-old patient, whose symptoms were caused by 
nerve compression via the  superior cerebellar artery and anterior inferior cerebellar artery.31 In a 
study of female pediatric patients at John Hopkins, 5 of the 6 cases also experienced complete pain 
relief via MVD.16 Complications that have been associated with MVD include CSF leaks, 
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infection, diplopia, meningitis, cerebellar lesions, and cranial nerve deficits.16,18 Resnick et al. 
expressed some hesitancy for this procedure due to the involvement of varying vessels and 
increased recovery time.15Although the success of MVD in our series was observed over relatively 
short follow-up periods, the durability of the results following MVD have been generally 
favorable in the literature. Of 52 pediatric patients among 9 series, complete response to MVD 
was observed in 33 cases while partial response was seen in 17 cases at follow-up times ranging 
from 6 months to 18 years.4,12,15,16,19,20,23,28,31  
       Other surgical procedures used in the treatment of pediatric trigeminal neuralgia include 
percutaneous balloon compression, and peripheral glycerol injection.19 The percutaneous balloon 
compression performed by Baabor demonstrated high success rate, low recurrence rate, low cost, 
and a low morbidity rate.32 Peripheral glycerol injection has been previously tried for the relief of 
facial neuralgia, and is a less complex procedure, as it can easily be performed and repeated as 
necessary. Furthermore, there is no risk of facial sensory loss as compared to other procedures.19   
Conclusions 
MVD is a useful treatment option for those diagnosed with TN. It is a widely accepted first 
line surgical therapy for adult patients and has been reported in the pediatric population as an 
effective treatment modality for facial pain reduction. Earlier decision for surgical intervention 
should be considered for pediatric patients with TN1 and documented neurovascular conflict. The 
enclosed video demonstrates the surgical technique of an MVD in one of the cases with 
neurovascular conflict herein presented.  Our cases, as well as those reviewed in this paper, 
support the use of MVD in pediatric populations suffering from TN. The procedure shows 
promising success rates of pain reduction and treatment of the disease, with minimal side effects. 
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Figure Legends:  
Figure 1: Axial T1 post gadolinium demonstrating a branch of anterior inferior cerebellar artery 
(AICA) (white arrow) coursing superiorly along the dorsal root entry zone of the right trigeminal 
nerve (black arrow). 
Figure 2: Coronal and axial T2 FIESTA demonstrating a redundant course of the Labyrinthine 
artery medial and inferior to the left Trigeminal Nerve (arrows point to vessel in plane, dotted line 
represents vessel course out of plane). 
Video: The video commences following a left retrosigmoidectomy and dural opening. The 
cerebellum is retracted. The superficial petrosal venous complex is coagulated and divided. The 
trigeminal nerve is identified. A venous complex is identified circumferentially around the 
trigeminal nerve, which is released with microsurgery. Teflon plegets are placed to decompress 
the neurovascular structure.  
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Table 1. Previous Reported Cases of Pediatric Trigeminal Neuralgia Treated via Surgery 
 
 
Author Number of 
Patients 
Age of 
Treatment 
Sex Treatment  
Modality 
Response Duration 
of relief 
Barclay 1 11 M Division 
of V2 and 
V3 
Success 17m, 
ongoing 
 
(follow up 
duration 
after this 
is 
unknown) 
Bender 5 3-18 
(mean age 
11.7) 
F MVD Complete 
Success 
(5 of 6 cases; 
partial in 1 
case= >50% 
reduction in 
attack 
frequency + 
severity)  
Ongoing 
 
 
 
(Follow 
up 
duration: 
9.1-
24.8m) 
Childs 2 9,12 M MVD Success 13m, 
Ongoing 
 
 
(Follow 
up 
duration 
after this 
is 
unknown) 
Harris 1 4.5 F Glycerol 
alcohol 
injection 
Success 7m, 
ongoing 
 
(Follow 
up 
duration 
after this 
is 
unknown) 
Mason 1 Aprx 7 
(dx= 13 
month) 
F MVD Success 6m, 
ongoing 
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(Follow 
up: 2 
years) 
Resnick 22 29.1 +/- 
12.8 yr 
(onset at 
13.6 +/- 
4.6 yr)  
7M, 15F MVD Initial: 
16 complete 
success; 3 
partial; 3 
operative 
complications 
 
Follow Up: 
9 complete 
success,2 
partial, 10 
<75% 
reduction in 
pain 
12-225m, 
ongoing  
 
 
 
 
 
 
(Follow 
up 
duration 
after this 
is 
unknown) 
Roski 1 10 M MVD Success 2 years, 
Ongoing 
 
(Follow 
up 
duration 
after this 
is 
unknown) 
Solth 1 11 M MVD Success 6m, 
Ongoing 
 
 
(Follow 
up 
duration 
after this 
is 
unknown) 
Yue 18 10–14 11M,7F peripheral 
glycerol 
injection 
72% 
Complete 
relief w/o 
medication 
11.1% 
complete 
relief but use 
medication 
11.1% 
pain relief < 
3 years, 
ongoing  
 
 
 
 
 
 
 
(Follow 
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50% 
 
22.2% 
recurrence 2-
13m 
up 
duration 
after this 
is 
unknown) 
 
MVD = microvascular decompression. 
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TN = Trigeminal neuralgia 
 
MVD = microvascular decompression  
 
SRS = stereotactic radiosurgery  
 
OCD = obsessive-compulsive disorder  
 
DREZ = dorsal root entry zone  
 
AICA = anterior inferior cerebellar artery 
